Mechanisms that clear mutations drive field cancerization in mammary tissue
Author:
Ciwinska Marta, Messal Hendrik A.ORCID, Hristova Hristina R., Lutz Catrin, Bornes LauraORCID, Chalkiadakis Theofilos, Harkes Rolf, Langedijk Nathalia S. M.ORCID, Hutten Stefan J.ORCID, Menezes Renée X., Jonkers JosORCID, Prekovic Stefan, , Wesseling Jelle, Thompson Alastair M., Nik-Zainal Serena, Sawyer Elinor J., Davies Helen R., Futreal Andrew, Navin Nicholas E., Hwang E. Shelley, Jonkers Jos, van Rheenen Jacco, Behbod Fariba, Lips Esther H., Schmidt Marjanka, Wessels Lodewyk F. A., Rea Daniel, Bhattacharjee Proteeti, Stobart Hilary, Collyar Deborah, Pinto Donna, Verschuur Ellen, van Oirsouw Marja, Simons Benjamin D.ORCID, Scheele Colinda L. G. J.ORCID, van Rheenen JaccoORCID
Abstract
AbstractOncogenic mutations are abundant in the tissues of healthy individuals, but rarely form tumours1–3. Yet, the underlying protection mechanisms are largely unknown. To resolve these mechanisms in mouse mammary tissue, we use lineage tracing to map the fate of wild-type and Brca1−/−;Trp53−/− cells, and find that both follow a similar pattern of loss and spread within ducts. Clonal analysis reveals that ducts consist of small repetitive units of self-renewing cells that give rise to short-lived descendants. This offers a first layer of protection as any descendants, including oncogenic mutant cells, are constantly lost, thereby limiting the spread of mutations to a single stem cell-descendant unit. Local tissue remodelling during consecutive oestrous cycles leads to the cooperative and stochastic loss and replacement of self-renewing cells. This process provides a second layer of protection, leading to the elimination of most mutant clones while enabling the minority that by chance survive to expand beyond the stem cell-descendant unit. This leads to fields of mutant cells spanning large parts of the epithelial network, predisposing it for transformation. Eventually, clone expansion becomes restrained by the geometry of the ducts, providing a third layer of protection. Together, these mechanisms act to eliminate most cells that acquire somatic mutations at the expense of driving the accelerated expansion of a minority of cells, which can colonize large areas, leading to field cancerization.
Publisher
Springer Science and Business Media LLC
Reference69 articles.
1. Cereser, B. et al. The mutational landscape of the adult healthy parous and nulliparous human breast. Nat. Commun. 14, 5136 (2023). 2. Hutten, S. J. et al. Ductal carcinoma in situ develops within clonal fields of mutant cells in morphologically normal ducts. J. Pathol. 263, 360–371 (2024). 3. Martincorena, I. & Campbell, P. J. Somatic mutation in cancer and normal cells. Science 349, 1483–1489 (2015). 4. Kuchenbaecker, K. B. et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317, 2402 (2017). 5. Ford, D., Easton, D. F., Bishop, D. T., Narod, S. A. & Goldgar, D. E. Risks of cancer in BRCA1-mutation carriers. Lancet https://doi.org/10.1016/S0140-6736(94)91578-4 (1994).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|